Antimicrobial efficacy of gentamicin-loaded acrylic bone cements with fusidic acid or clindamycin added

Journal of Orthopaedic Research

Volumn 24, Issue 2, 2006, Pages 291-299

  Neut, Daniëlle ^a   Hendriks, Johannes G E ^a   van Horn, Jim R ^a   Kowalski, Rick S Z ^b   van der Mei, Henny C ^a   Busscher, Henk J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Johnson Johnson Company   (United Kingdom)

Author keywords

Acrylic bone cement; Antimicrobial susceptibility; Clindamycin; Fusidic acid; Gentamicin

Indexed keywords

ACRYLIC CEMENT; CLINDAMYCIN; FUSIDIC ACID; GENTAMICIN; ANTIINFECTIVE AGENT; BONE CEMENT;

AGAR MEDIUM; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIUM ISOLATE; BONE PROSTHESIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; ENDOPROSTHESIS LOOSENING; HUMAN; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; DRUG COMBINATION; DRUG EFFECT; GRAM NEGATIVE BACTERIUM; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGICAL EXAMINATION;

ANTI-BACTERIAL AGENTS; BONE CEMENTS; CLINDAMYCIN; DRUG COMBINATIONS; DRUG SYNERGISM; FUSIDIC ACID; GENTAMICINS; GRAM-NEGATIVE BACTERIA; MICROBIAL SENSITIVITY TESTS;

EID: 33645060773     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20058     Document Type: Article

References (37)

1. Espehaug B, Engesaeter LB, Vollset SE, et al. 1997. Antibiotic prophylaxis in total hip arthroplasty. Review of 10,905 primary cemented total hip replacements reported to the Norwegian arthroplasty register, 1987 to 1995. J Bone Joint Surg Br 79:590-595.
2. Josefsson G, Kolmert L. 1993. Prophylaxis with systematic antibiotics versus gentamicin bone cement in total hip arthroplasty. A ten-year survey of 1,688 hips. Clin Orthop 292:210-214.
3. Fletcher MD, Spencer RF, Langkamer VG, et al. 2004. Gentamicin concentrations in diagnostic aspirates from 25 patients with hip and knee arthroplasties. Acta Orthop Scand 75:173-176.
4. Wahlig H, Dingeldein E. 1980. Antibiotics and bone cements. Experimental and clinical long-term observations. Acta Orthop Scand 51:49-56.
5. Mc Gowan JE Jr, Terry PM, Huang TS, et al. 1979. Nosocomial infections with gentamicin-resistant Staphylococcus aureus: plasmid analysis as an epidemiologic tool. J Infect Dis 140:864-872.
6. Speller DC, Raghunath D, Stephens M, et al. 1976. Epidemic infection by a gentamicin-resistant Staphylococcus aureus in three hospitals. Lancet 1: 464-466.
7. Wyatt TD, Ferguson WP, Wilson TS, et al. 1977. Gentamicin resistant Staphylococcus aureus associated with the use of topical gentamicin. J Antimicrob Chemother 3:213-217.
8. Musher DM. 1988. The Gram-positive cocci: III. Resistance to antibiotics. Hosp Pract (Off Ed) 23: 105-124.
9. Chiu FY, Chen CM, Lin CF, et al. 2002. Cefuroxime-impregnated cement in primary total knee arthroplasty: a prospective, randomized study of three hundred and forty knees. J Bone Joint Surg Am 84-A:759-762.
10. Nijhof MW, Dhert WJ, Fleer A, et al. 2000. Prophylaxis of implant-related staphylococcal infections using tobramycin-containing bone cement. J Biomed Mater Res 52:754-761.
11. Murray PR, Pfaller MA, Rosenthal KS, et al. 1998. Medical microbiology. In: Antibacterial agents, 3rd ed. St. Louis, MO: Mosby; p 165-168.
12. Penner MJ, Masri BA, Duncan CP. 1996. Elution characteristics of vancomycin and tobramycin combined in acrylic bone cement. J Arthroplasty 11:939-944.
13. Baker AS, Greenham LW. 1988. Release of gentamicin from acrylic bone cement. Elution and diffusion studies. J Bone Joint Surg A 70:1551-1557.
14. Kühn KD. 2000. Bone cements up-to-date comparison of physical and chemical properties of commercial materials. Berlin: Springer-Verlag. p 228-258.
15. Buchholz HW, Engelbrecht H. 1970. Depot effects of various antibiotics mixed with Palacos resins. Chirurg 41:511-515.
16. Davies J, O'Connor DO, Harris WH. 1984. Comparison of the mechanical properties of Palacos, Palacos-gentamicin and Simplex P. Orthop Trans 8:400-401.
17. Hanssen AD, Osmon DR. 1999. The use of prophylactic antimicrobial agents during and after hip arthroplasty. Clin Orthop 369:124-138.
18. Wang JS, Franzen H, Lidgren L. 1999. Interface gap after implantation of a cemented femoral stem in pigs. Acta Orthop Scand 70:234-239.
19. Hendriks JGE, Neut D, Van Horn JR, et al. 2002. The release of gentamicin from acrylic bone cements in a simulated prosthesis-related interfacial gap. J Biomed Mater Res Appl Biomater 63: 1-5.
20. Neut D, Van Horn JR, Van Kooten TG, et al. 2003. Detection of biomaterial-associated infections in orthopaedic joint implants. Clin Orthop 413:261-268.
21. Fitzgerald RH Jr. 1995. Infected total hip arthroplasty: diagnosis and treatment. J Am Acad Orthop Surg 3:249-262.
22. Garvin KL, Hinrichs SH, Urban JA. 1999. Emerging antibiotic-resistant bacteria. Their treatment in total joint arthroplasty. Clin Orthop 369:110-123.
23. Hope PG, Kristinsson KG, Norman P, et al. 1989. Deep infection of cemented total hip arthroplasties caused by coagulase-negative staphylococci. J Bone Joint Surg Br 71-B:851-855.
24. Thomes B, Murray P, Bouchier-Hayes D. 2002. Development of resistant strains of Staphylococcus epidermidis on gentamicin-loaded bone cement in vivo. J Bone Joint Surg Br 84-B:758-760.
25. Hendriks JGE, Neut D, Van Horn JR, et al. 2005. Bacterial survival in the interfacial gap in gentamicin-loaded acrylic bone cements. J Bone Joint Surg Br 87-B:272-276.
26. Arciola CR, Campoccia D, Montanaro L. 2002. Effects on antibiotic resistance of Staphylococcus epidermidis following adhesion to polymethyl-methacrylate and to silicone surfaces. Biomaterials 23:1495-1502.
27. Collignon P, Turnidge J. 1999. Fusidic acid in vitro activity. Int J Antimicrob Agents 12:S45-S58.
28. Atkins B, Gottlieb T. 1999. Fusidic acid in bone and joint infections. Int J Antimicrob Agents 12:S79-S93.
29. Hill J, Klenerman L, Trustey S, et al. 1977. Diffusion of antibiotics from acrylic bone cement in vitro. J Bone Joint Surg Br 59:197-199.
30. Bayston R, Milner RD. 1982. The sustained release of antimicrobial drugs from bone cement. An appraisal of laboratory investigations and their significance. J Bone Joint Surg Br 64:460-464.
31. Beeching NJ, Thomas MG, Roberts S, et al. 1986. Comparative in vitro activity of antibiotics incorporated in acrylic bone cement. J Antimicrob Chemother 17:173-184.
32. Konig DP, Schierholz JM, Hilgers RD, et al. 2001. In vitro adherence and accumulation of Staphylococcus epidermidis RP 62 A and Staphylococcus epidermidis M7 on four different bone cements. Langenbecks Arch Surg 386:328-332.
33. Betriu C, Redondo M, Boloix A, et al. 2001. Comparative activity of linezolid and other new agents against methicillin-resistant Staphylococcus aureus and teicoplanin-intermediate coagulase-negative staphylococci. J Antimicrob Chemother 48:911-913.
34. Holmberg SD, Solomon SL, Blake PA. 1987. Health and economic impacts of antimicrobial resistance. Rev Infect Dis 9:1065-1078.
35. Maple PA, Hamilton-Miller JM, Brumfitt W. 1989. World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus. Lancet 1:537-540.
36. Huebner J, Kropec A, Engels I, et al. 1992. In vitro susceptibility of methicillin-resistant Staphylococcus aureus and slime-producing and non-slime-producing coagulase-negative staphylococci to fusidic acid. Chemotherapy 38:206-210.
37. Neut D, Van de Belt H, Stokroos I, et al. 2001. Biomaterials-associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery. J Antimicrob Chemother 47:885-891.